The economic evaluation of prevention--let's talk about values and the case of discounting.
Schwappach
David L B
DL
Research Institute for Public Health and Addiction (ISGF), WHO Collaborating Centre for Substance Abuse, Zurich, Switzerland. david.schwappach@isgf.unizh.ch
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006293:Health Promotion / Q000191:economics*; D006801:Humans; D008875:Middle Aged; D011315:Preventive Medicine / Q000191:economics*; D011322:Primary Prevention / Q000191:economics*